Cardinal Health stock holds firm after a $63.67 billion quarter
Published on 08/27/2026 at 12:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cardinal Health, Inc. stock (US14149Y1082) held at $238.61 as of August 27, 2026, after the company reported fiscal Q4 2026 revenue of $63.67 billion and adjusted EPS of $2.91 on August 11, 2026. The quarter also beat the consensus EPS estimate by $0.49 and came on revenue that was 5.8% higher year over year.
Quarterly numbers matter
The latest reported quarter gives investors three clean reference points: $63.67 billion in revenue, $2.91 in EPS, and a 5.8% year-over-year sales increase. Revenue still trailed analyst estimates of $65.15 billion, which keeps the debate centered on margins and mix rather than headline growth alone.
That setup matters because the company also set FY 2027 guidance at 12.400 to 12.600 EPS, while analysts currently model 12.55 EPS for the current fiscal year. The spread between the company guide and the Street estimate is narrow, so even small changes in operating performance can move sentiment.
Consensus and valuation
Market data tied to the August 27, 2026 session showed Cardinal Health with a market cap of $55.50 billion, a P/E ratio of 33.00, and a 12-month range of $145.87 to $258.30. The stock opened at $238.61, leaving it below the high but well above the low from the same 12-month window.
Analyst positioning is also constructive, with a consensus rating of Moderate Buy and an average price target of $266.56. One cited research note from August 13, 2026 lifted a target to $275.00 and assigned an overweight view, which helps explain why the valuation debate remains tied to earnings power rather than a simple rerating.
Healthcare distribution scale
Cardinal Health's distribution model still rests on the scale of its pharmaceutical and medical supply channels, which makes revenue growth and margin execution the key levers in every quarterly update. The August 11, 2026 results showed how much the market is still weighing volume growth against the revenue miss versus expectations.
For investors, the cleanest read is that Cardinal Health is trading with a full valuation and a closely watched earnings base. The stock's August 27, 2026 opening level of $238.61 sits between the 12-month low of $145.87 and the high of $258.30, leaving limited room for a sloppy quarter.
More on Cardinal Health stock
The company's core products run through pharmaceutical distribution and medical supplies, a mix that supports large revenue lines but also leaves less room for pricing error when trading conditions change.
Cardinal Health stock price
As of August 27, 2026, Cardinal Health traded at $238.61 in the opening session on NYSE, with a market cap of $55.50 billion and a 12-month range of $145.87 to $258.30.
Fact box
Company: Cardinal Health, Inc.
ISIN: US14149Y1082
Ticker: CAH
Exchange: NYSE
Price (as of August 27, 2026): $238.61 USD
Market cap: $55.50 billion (as of August 27, 2026)
Sector / Industry: Health Care / Healthcare Distribution
Index membership: S&P 500
